Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (399)

« Back to Publications

Development and Evaluation of Compact Semi-Synthetic Promoters for Enhanced Antigen Expression in Adenoviral-Vectored Vaccines

Hlaváč M. et al, (2026), Vaccines, 14, 260 - 260

Biochemical profiling provides a low-cost and globally accessible method to detect falsified vaccines and insulin

Brook J. et al, (2026), Scientific Reports, 16

Replication-incompetent viral vaccine vectors ChAdOx1 and MVA as tools for evaluating T-cell responses to naturally processed antigens in vitro.

Nazki S. et al, (2026), Virus research, 364

Developing the next-generation of adenoviral vector vaccines.

Sampson AT. et al, (2025), Human vaccines & immunotherapeutics, 21

Shear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: a novel biophysical mechanism for arterial thrombosis

Chen YC. et al, (2025), Blood, 146, 496 - 503

Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public health.

McLean RK. et al, (2025), NPJ vaccines, 10

Priorities for rapid and cost-effective vaccines to improve outbreak responses

Gilbert SC., (2025), PLOS Biology, 23, e3003114 - e3003114

Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials

Venkatraman N. et al, (2025), The Lancet Microbe, 6, 100868 - 100868

A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's disease

Sanderson J. et al, (2025), eBioMedicine, 113, 105570 - 105570

Aerosol immunization with influenza matrix, nucleoprotein, or both prevents lung disease in pig.

Vatzia E. et al, (2024), NPJ vaccines, 9

Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine

Wee EG-T. et al, (2024), Vaccines, 12, 965 - 965

Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-cell Vaccine

Wee EG-T. et al, (2024)

Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse

Flaxman A. et al, (2024), PLOS Pathogens, 20, e1012262 - e1012262

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine.

Bissett C. et al, (2024), NPJ vaccines, 9

Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease

Drury RE. et al, (2024), Nature Communications, 15

Load More

1
2
3
4
5
6
7
...
»